CD40 and rectal cancer: We measured 84 circulating proteins associated with angiogenesis and inflammation in pre-treatment serum specimens sampled within a population-based study cohort of stage I–III rectal cancer patients and identified the soluble form of the CD40 costimulatory immune checkpoint receptor27 being a strong prognostic marker of the time to development of liver metastasis.